Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Infectious Diseases

• Publication date

  1984-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INFDIS/149.2.194PMID 6699431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The rapid concentration and purification of influenza virus from allantoic fluid

  2005cited by this paper
• Laboratory-based surveillance of influenza A(H1N1) and A(H3N2) viruses in 1980-81: antigenic and genomic analyses.

  1983cited by this paper
• Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide.

  1983cited by this paper
• Development of cold-adapted recombinant live, attenuated influenza A vaccines in the U.S.A. and U.S.S.R.

  1982cited by this paper
• Cold-adapted recombinant influenza A virus vaccines in seronegative young children.

  1982influential reference
• Oligonucleotide mapping: evaluation of its sensitivity by computer- simulation

  1982cited by this paper
• Antigenic and genomic analyses of influenza A(H1N1) viruses from different regions of the world, February 1978 to March 1980

  1981cited by this paper
• Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers

  1981cited by this paper
• Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.

  1981cited by this paper
• Characterization and clinical evaluation of live influenza A vaccine prepared from a recombinant of the A/USSR/92/77 (H1N1) and the cold-adapted A/Ann Arbor/6/60 (H2N2) strains.

  1981cited by this paper
• Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans.

  1981cited by this paper
• GENETIC AND BIOCHEMICAL ANALYSIS OF THE A/ANN ARBOR/6/60 COLD-ADAPTED MUTANT

  1981cited by this paper
• Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus

  1980cited by this paper
• ESCAPE OF A HIGHLY DEFECTIVE INFLUENZA A VIRUS MUTANT FROM ITS TEMPERATURE SENSITIVE PHENOTYPE BY EXTRAGENIC SUPPRESSION AND OTHER TYPES OF MUTATION

  1980cited by this paper
• Studies in man with cold‐recombinant influenza virus (h1n1) live vaccines

  1980cited by this paper
• Genetic variability of Hong Kong (H3N2) influenza viruses: spontaneous mutations and their location in the viral genome.

  1980cited by this paper
• Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.

  1980cited by this paper
• Cold-Adapted Variants of Influenza A Virus: Evaluation in Adult Seronegative Volunteers of A/Scotland/840/74 and A/Victoria/3/75 Cold-Adapted Recombinants Derived from the Cold-Adapted A/Ann Arbor/6/60 Strain

  1979cited by this paper
• Evolution of human influenza A viruses in nature: sequential mutations in the genomes of new H1N1.

  1979cited by this paper
• Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60.

  1979cited by this paper
• Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines.

  1977cited by this paper
• Cold adapted variants of influenza A

  1977cited by this paper
• A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.

  1977cited by this paper
• Temperature-sensitive Mutants of Influenza A Virus: Response of Children to the Influenza A/Hong Kong/68-ts-1[E] (H3N2) and Influenza A/Udorn/72-ts-1[E] (H3N2) Candidate Vaccine Viruses and Significance of Immunity to Neuraminidase Antigen

  1976cited by this paper
• Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2).

  1975cited by this paper
• Adaptation and Growth Characteristics of Influenza Virus at 25° C

  1967cited by this paper
• Adaptation and growth characteristics of influenza virus at 25 degrees c.

  1967cited by this paper

• Epitope-Specific Antibody Immunodominance Driving Antibody and Influenza Viral Evolution During 2010- 2024.

  2025cites this paper
• Antibody-mediated Suppression Regulates the Humoral Immune Response to Influenza Vaccination in Humans.

  2023cites this paper
• A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity

  2020cites this paper
• The Immunological Basis for Immunization Series Module 23 : Influenza Vaccines Immunization

  2017cites this paper
• Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.

  2008cites this paper
• Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

  2006cites this paper
• Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

  2006cites this paper
• Diagnostic Approach for Differentiating Infected from Vaccinated Poultry on the Basis of Antibodies to NS1, the Nonstructural Protein of Influenza A Virus

  2005cites this paper
• Biological characteristics of a cold-adapted influenza A virus mutation residing on a polymerase gene

  2005cites this paper
• Comparative Susceptibility of Chickens and Turkeys to Avian Influenza A H7N2 Virus Infection and Protective Efficacy of a Commercial Avian Influenza H7N2 Virus Vaccine

  2004cites this paper
• Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.

  2004cites this paper
• Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine.

  2002cites this paper
• The role of live influenza vaccines in children.

  2002cites this paper
• Immunity to Influenza A H9N2 Viruses Induced by Infection and Vaccination

  2001cites this paper
• Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection

  2001cites this paper
• Induced by Infection and Vaccination Immunity to Influenza A H 9 N 2 Viruses

  2001cites this paper
• Mucosal vaccination protects mice against influenza A heterosubtypic challenge

  2001cites this paper
• A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice.

  2000cites this paper
• A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans

  1999cites this paper
• A practical approach to genetic screening for influenza virus variants

  1997cites this paper
• Virus retention by a hydrophilic triple-layer PVDF microporous membrane filter.

  1997cites this paper
• Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine.

  1997cites this paper
• A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children.

  1995cites this paper
• The HA1 of cold-adapted influenza B vaccine is not altered during replication in human vaccinees.

  1995cites this paper
• Removal of influenza A virus, phage T1, and PP7 from fluids with a nylon 0.04‐μM membrane filter

  1994cites this paper
• Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986-1991.

  1993cites this paper
• Human influenza A (H1N2) viruses isolated from China.

  1992cites this paper
• Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child

  1991cites this paper
• Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

  1990cites this paper
• Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.

  1990cites this paper
• Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza

  1989cites this paper
• Pathways of evolution of influenza A (H1N1) viruses from 1977 to 1986 as determined by oligonucleotide mapping and sequencing studies.

  1989cites this paper
• Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus.

  1988cites this paper
• Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).

  1988cites this paper
• The Control of Influenza

  1987cites this paper
• Temperature-sensitive defect of influenza A/Ann Arbor/6/60 cold-adapted variant leads to a blockage of matrix polypeptide incorporation into the plasma membrane of the infected cells.

  1987cites this paper
• Temperature-sensitive defect of influenza A/Ann Arbor/6/60 cold-adapted variant leads to a blockage of matrix polypeptide incorporation into the plasma membrane of the infected cells.

  1987cites this paper
• Oligonucleotide mapping of viral ribonucleic acid as an aid in identifying laboratory contaminants of influenza virus.

  1986cites this paper
• The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene.

  1986cites this paper
• The immune response to influenza infection.

  1986cites this paper
• Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza virus: detection of mutations in all genes of the A/Ann Arbor/6/60 (H2N2) mutant vaccine donor strain.

  1986cites this paper
• Comparative studies of A/Leningrad/134/57 wild-type and 47-times passaged cold-adapted mutant influenza viruses: oligonucleotide mapping and RNA-RNA hybridization studies.

  1985cites this paper